The Atomic Energy Regulatory Board (AERB) establishes HELP DESK for providing regulatory support to users of Radiation Facilities by Lexplosion | Sep 13, 2018 | Healthcare, OPS, Pharmaceuticals, statesThe Atomic Energy Regulatory Board has established a Help Desk for providing regulatory support to... Read More
Delhi HC stays Centre’s order preventing manufacture and sale of Oxytocin by Private manufacturers for a period of 1 month i.e. till 31.09.2018 by Lexplosion | Sep 6, 2018 | EHS, Healthcare, Pharmaceuticals, statesThe Delhi High Court has imposed a stay on the Central Government order banning the manufacture... Read More
MOHFW invites comments till 12.10.2018 on the draft ‘Sale of Drugs by e-Pharmacy’ (Part VIB) which it proposes to insert in the Drugs and Cosmetics Rules, 1945 by Lexplosion | Sep 5, 2018 | EHS, Healthcare, Pharmaceuticals, statesIn a notification dated August 28, 2018, the Ministry of Health and Family Welfare (“Ministry”)... Read More
Ministry of Health and Family Welfare proposes to exempt Gelatine capsules from labelling requirement under the Drugs and Cosmetics Rules, 1945 by Lexplosion | Aug 21, 2018 | EHS, Healthcare, Pharmaceuticals, statesThe Ministry of Health and Family Welfare (“Ministry”) has published the Draft Drugs and Cosmetics... Read More
NPPA extends the period of ceiling prices of Orthopaedic knee implants till 15th August, 2019 by Lexplosion | Aug 17, 2018 | EHS, Pharmaceuticals, statesIn a recent notification dated 16th August, 2018, the National Pharmaceutical Pricing Authority... Read More
Ministry of Health and Family Welfare invites comments on its plan to re-classify ‘Oxytocin as a Schedule H1 category Drug’ till 17th August, 2018 by Lexplosion | Aug 13, 2018 | EHS, Pharmaceuticals, statesThe Ministry of Health and Family Welfare (“Ministry”) proposes to omit oxytocin from the category... Read More
